Goldman Sachs Group Inc Teva Pharmaceutical Industries LTD Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,965,257 shares of TEVA stock, worth $65.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,965,257

Previous 10,376,557 61.79%

Holding current value

$65.6 Million

Previous $159 Million 61.79%

% of portfolio

0.01%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 16, 2025	SELL	$14.67 - $22.01 $94.1 Million - $141 Million	-6,411,300 Reduced 61.79%	3,965,257 $60.9 Million
Q1 2025 May 09, 2025	BUY	$14.67 - $22.01 $101 Million - $151 Million	6,859,718 Added 195.05%	10,376,557 $159 Million
Q4 2024 Feb 11, 2025	SELL	$16.43 - $22.77 $10.5 Million - $14.6 Million	-641,489 Reduced 15.43%	3,516,839 $77.5 Million
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $2.09 Million - $2.51 Million	-132,319 Reduced 3.08%	4,158,328 $74.9 Million
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $9.54 Million - $13 Million	746,787 Added 21.07%	4,290,647 $69.7 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $2.79 Million - $3.77 Million	-261,488 Reduced 6.87%	3,543,860 $50 Million
Q4 2023 Feb 13, 2024	SELL	$8.12 - $10.63 $5.15 Million - $6.74 Million	-633,945 Reduced 14.28%	3,805,348 $39.7 Million
Q3 2023 May 14, 2024	BUY	$7.48 - $10.7 $4.74 Million - $6.78 Million	633,945 Added 16.66%	4,439,293 $45.3 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $826,839 - $1.18 Million	-110,540 Reduced 2.43%	4,439,293 $45.3 Million
Q2 2023 May 14, 2024	SELL	$7.2 - $9.47 $758,001 - $996,982	-105,278 Reduced 2.26%	4,549,833 $34.3 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $758,001 - $996,982	-105,278 Reduced 2.26%	4,549,833 $34.3 Million
Q1 2023 May 14, 2024	SELL	$8.36 - $11.37 $5.71 Million - $7.77 Million	-683,033 Reduced 12.8%	4,655,111 $41.2 Million
Q1 2023 May 11, 2023	SELL	$8.36 - $11.37 $5.71 Million - $7.77 Million	-683,033 Reduced 12.8%	4,655,111 $41.2 Million
Q4 2022 May 14, 2024	BUY	$7.95 - $9.48 $945,883 - $1.13 Million	118,979 Added 2.28%	5,338,144 $48.7 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $945,883 - $1.13 Million	118,979 Added 2.28%	5,338,144 $48.7 Million
Q3 2022 May 14, 2024	BUY	$6.86 - $11.95 $2.75 Million - $4.78 Million	400,197 Added 8.3%	5,219,165 $42.1 Million
Q3 2022 Nov 10, 2022	BUY	$6.86 - $11.95 $2.75 Million - $4.78 Million	400,197 Added 8.3%	5,219,165 $42.1 Million
Q2 2022 May 14, 2024	BUY	$7.38 - $10.4 $7.48 Million - $10.5 Million	1,013,620 Added 26.64%	4,818,968 $36.2 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $10.5 Million - $14.8 Million	1,425,393 Added 42.0%	4,818,968 $36.2 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $5.17 Million - $6.63 Million	-705,599 Reduced 17.21%	3,393,575 $31.9 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $6.62 Million - $8.54 Million	837,955 Added 25.69%	4,099,174 $32.8 Million
Q3 2021 Nov 10, 2021	BUY	$8.38 - $10.18 $27.3 Million - $33.2 Million	3,261,219 New	3,261,219 $31.8 Million

Others Institutions Holding TEVA

# of Institutions

660

Shares Held

627M

Call Options Held

27.9M

Put Options Held

21.8M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Teva Pharmaceutical Industries LTD Transaction History